Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a non-smoker
- You are willing to sign a consent form agreeing to take part in the study
- You have been told you have subjective cognitive impairment or mild cognitive impairment (meaning you may notice memory or thinking difficulties, or a doctor has identified mild changes)
- Certain biological markers in your body suggest early signs of a process linked to Alzheimer's disease
- There are no personal, psychological, or practical circumstances that would make it very difficult for you to take part
Who may not be able to join:
- You have serious heart, liver, or kidney disease; diabetes that is poorly controlled or treated with insulin or certain diabetes injections; cancer; or another serious illness as judged by a doctor
- You have had cancer treated with chemotherapy or radiotherapy within the last 5 years
- You are unable to cooperate, have a very rigid schedule, or have major difficulties with transport
- You do not have enough physical ability to take part in an exercise programme, as assessed by relevant specialists
- You have a pacemaker or metal implants in your body (which would prevent an MRI scan), or you are allergic to local anaesthetics (which would prevent a muscle sample being taken)
- You smoke, are dependent on alcohol, or use other addictive substances
- You have had a stroke or heart attack within the last year
- You are receiving long-term treatment for a psychiatric condition (although treated and stable depression is not automatically a reason to be excluded — confirm with trial site)
- You have conditions affecting your muscles, joints, or nervous system that could interfere with exercise or thinking — for example, severe arthritis, Parkinson's disease, significant tremor, or epilepsy
- You are currently taking part in another clinical trial
- You are taking cholinesterase inhibitor medications, unless you have been on the same stable dose for a period of time (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Barbora Ukropcova, Prof., Biomedical Research Center Slovak Academy of Science
Phone: +421911643630
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Impact on Cognitive Functions; Effect of Interventions on Neurodegeneration Markers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.